Foreword

• Pages: 13-13

xiii

FOREWORD

The Section of Antitrust Law of the American Bar Association is

pleased to present the Pharmaceutical Industry Antitrust Handbook,

Second Edition. This handbook is intended to provide comprehensive

guidance about the analysis of the most important antitrust questions faced

today by pharmaceutical companies and participants in related health care

industries, and is designed to update the original Handbook, published in

2009.

The Handbookprovides an overview of the pharmaceutical industry,

including the market participants, FDA regulatory structure, and

background on private litigation and government enforcement. It then

addresses the substantive antitrust issues presented by mergers and

acquisition, joint ventures, various forms of potentially anticompetitive

conduct, and distribution. Finally, it discusses the kinds of economic data

that are integral to antitrust analysis for this industry.

The Section of Antitrust Law is grateful to Second Edition editors

Jacqueline Grise and Richard Coe, who applied their substantial

experience regarding these markets to this edition and who devoted

extensive time and effort to its preparation. We believe this Second

Edition provides a valuable and unique resource to both the antitrust and

pharmaceutical communities.

March2018 Jonathan M. Jacobson

Chair, Section of Antitrust Law

American Bar Association

2017-2018